BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 35303618)

  • 1. Global burden of oropharyngeal cancer attributable to human papillomavirus by anatomical subsite and geographic region.
    Lu Y; Xie Z; Luo G; Yan H; Qian HZ; Fu L; Wang B; Huang R; Cao F; Lin H; You R; Tan L; Yu T; Chen M; Li C; Liu X; Lei W; Zou H
    Cancer Epidemiol; 2022 Jun; 78():102140. PubMed ID: 35303618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human papillomavirus and p16
    Lu Y; Clifford GM; Fairley CK; Grulich AE; Garland SM; Xiao F; Wang Y; Zou H
    Int J Cancer; 2024 Mar; 154(5):830-841. PubMed ID: 37861207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Worldwide trend in human papillomavirus-attributable cancer incidence rates between 1990 and 2012 and Bayesian projection to 2030.
    Wu J; Xiao F; Zheng Y; Lin Y; Wang HL
    Cancer; 2021 Sep; 127(17):3172-3182. PubMed ID: 33974715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The evolving landscape of human papillomavirus-related oropharyngeal squamous cell carcinoma at a single institution in Northern Italy.
    Morbini P; Alberizzi P; Ferrario G; Capello G; De Silvestri A; Pedrazzoli P; Tinelli C; Benazzo M
    Acta Otorhinolaryngol Ital; 2019 Feb; 39(1):9-17. PubMed ID: 30936574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of human papillomavirus and survival in oropharyngeal cancer other than tonsil or base of tongue cancer.
    Marklund L; Näsman A; Ramqvist T; Dalianis T; Munck-Wikland E; Hammarstedt L
    Cancer Med; 2012 Aug; 1(1):82-8. PubMed ID: 23342257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of human papillomavirus-related oropharyngeal cancer in a classically low-burden region of southern Europe.
    Mena M; Frias-Gomez J; Taberna M; Quirós B; Marquez S; Clavero O; Baena A; Lloveras B; Alejo M; León X; García J; Mesía R; Bermejo O; Bonfill T; Aguila A; Guix M; Hijano R; Pavón MA; Torres M; Tous S; Clèries R; Alemany L
    Sci Rep; 2020 Aug; 10(1):13219. PubMed ID: 32764593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis.
    Ndiaye C; Mena M; Alemany L; Arbyn M; Castellsagué X; Laporte L; Bosch FX; de Sanjosé S; Trottier H
    Lancet Oncol; 2014 Nov; 15(12):1319-31. PubMed ID: 25439690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increasing prevalence of HPV in oropharyngeal carcinoma suggests adaptation of p16 screening in Southeast Asia.
    Argirion I; Zarins KR; McHugh J; Cantley RL; Teeramatwanich W; Laohasiriwong S; Kasemsiri P; Naruikon J; Srimanta P; Chinn SB; Vatanasapt P; Rozek LS
    J Clin Virol; 2020 Nov; 132():104637. PubMed ID: 32932151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HPV Involvement in Head and Neck Cancers: Comprehensive Assessment of Biomarkers in 3680 Patients.
    Castellsagué X; Alemany L; Quer M; Halec G; Quirós B; Tous S; Clavero O; Alòs L; Biegner T; Szafarowski T; Alejo M; Holzinger D; Cadena E; Claros E; Hall G; Laco J; Poljak M; Benevolo M; Kasamatsu E; Mehanna H; Ndiaye C; Guimerà N; Lloveras B; León X; Ruiz-Cabezas JC; Alvarado-Cabrero I; Kang CS; Oh JK; Garcia-Rojo M; Iljazovic E; Ajayi OF; Duarte F; Nessa A; Tinoco L; Duran-Padilla MA; Pirog EC; Viarheichyk H; Morales H; Costes V; Félix A; Germar MJ; Mena M; Ruacan A; Jain A; Mehrotra R; Goodman MT; Lombardi LE; Ferrera A; Malami S; Albanesi EI; Dabed P; Molina C; López-Revilla R; Mandys V; González ME; Velasco J; Bravo IG; Quint W; Pawlita M; Muñoz N; de Sanjosé S; Xavier Bosch F;
    J Natl Cancer Inst; 2016 Jun; 108(6):djv403. PubMed ID: 26823521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Squamous cell carcinoma of the oropharynx in Australian males induced by human papillomavirus vaccine targets.
    Hong AM; Grulich AE; Jones D; Lee CS; Garland SM; Dobbins TA; Clark JR; Harnett GB; Milross CG; O'Brien CJ; Rose BR
    Vaccine; 2010 Apr; 28(19):3269-72. PubMed ID: 20226244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential impact of a nonavalent HPV vaccine on the occurrence of HPV-related diseases in France.
    Riethmuller D; Jacquard AC; Lacau St Guily J; Aubin F; Carcopino X; Pradat P; Dahlab A; Prétet JL
    BMC Public Health; 2015 May; 15():453. PubMed ID: 25934423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New evidence for geographic variation in the role of human papillomavirus in tonsillar carcinogenesis.
    Li W; Tran N; Lee SC; O'Brien CJ; Tse GM; Scolyer RA; Hong A; Milross C; Yu KH; Rose BR
    Pathology; 2007 Apr; 39(2):217-22. PubMed ID: 17454751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P16(INK4A) immunostaining is a strong indicator for high-risk-HPV-associated oropharyngeal carcinomas and dysplasias, but is unreliable to predict low-risk-HPV-infection in head and neck papillomas and laryngeal dysplasias.
    Mooren JJ; Gültekin SE; Straetmans JM; Haesevoets A; Peutz-Kootstra CJ; Huebbers CU; Dienes HP; Wieland U; Ramaekers FC; Kremer B; Speel EJ; Klussmann JP
    Int J Cancer; 2014 May; 134(9):2108-17. PubMed ID: 24127203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer incidence in Germany attributable to human papillomavirus in 2013.
    Buttmann-Schweiger N; Deleré Y; Klug SJ; Kraywinkel K
    BMC Cancer; 2017 Oct; 17(1):682. PubMed ID: 29037233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in incidence and prevalence of human papillomavirus in tonsillar and base of tongue cancer during 2000-2016 in the Stockholm region and Sweden.
    Haeggblom L; Attoff T; Yu J; Holzhauser S; Vlastos A; Mirzae L; Ährlund-Richter A; Munck-Wikland E; Marklund L; Hammarstedt-Nordenvall L; Ye W; Ramqvist T; Näsman A; Dalianis T
    Head Neck; 2019 Jun; 41(6):1583-1590. PubMed ID: 30584688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus infection and p16 overexpression in oropharyngeal squamous cell carcinoma: a case series from 2010 to 2014.
    Donà MG; Spriano G; Pichi B; Rollo F; Laquintana V; Covello R; Pellini R; Giuliani M; Pescarmona E; Benevolo M
    Future Microbiol; 2015; 10(8):1283-91. PubMed ID: 26228531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between human papilloma virus/Epstein-Barr virus coinfection and oral carcinogenesis.
    Jiang R; Ekshyyan O; Moore-Medlin T; Rong X; Nathan S; Gu X; Abreo F; Rosenthal EL; Shi M; Guidry JT; Scott RS; Hutt-Fletcher LM; Nathan CA
    J Oral Pathol Med; 2015 Jan; 44(1):28-36. PubMed ID: 25040496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus (HPV) in Chinese oropharyngeal squamous cell carcinoma (OPSCC): A strong predilection for the tonsil.
    Xu T; Shen C; Wei Y; Hu C; Wang Y; Xiang J; Sun GH; Su F; Wang Q; Lu X
    Cancer Med; 2020 Sep; 9(18):6556-6564. PubMed ID: 32717137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A global epidemic increase of an HPV-induced tonsil and tongue base cancer - potential benefit from a pan-gender use of HPV vaccine.
    Näsman A; Du J; Dalianis T
    J Intern Med; 2020 Feb; 287(2):134-152. PubMed ID: 31733108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human papillomavirus (HPV), HPV-associated oropharyngeal cancer, and HPV vaccine in the United States--do we need a broader vaccine policy?
    Osazuwa-Peters N
    Vaccine; 2013 Nov; 31(47):5500-5. PubMed ID: 24095883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.